HDE supplement
H020007 S372: Activa, Percept and SenSight Deep Brain Stimulation Therapy System
FDA HDE supplement · normal 75 day track · MEDTRONIC NEUROMODULATION
Key facts
| Original HDE | H020007 |
|---|---|
| Supplement number | S372 |
| Supplement type | normal 75 day track |
| Reason for the supplement | change design/components/specifications/material |
| Trade name | Activa, Percept and SenSight Deep Brain Stimulation Therapy System |
| Generic name | Implanted subcortical electrical stimulator (motor disorders) |
| Applicant | MEDTRONIC NEUROMODULATION |
| Product code | MRU |
| Received date | Jun 20, 2024 |
| Decision date | Feb 20, 2025 |
At a glance
- No Approval order on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About HDE supplements
An HDE supplement asks FDA to approve a change to a Humanitarian Use Device that already holds a humanitarian device exemption.
Source: U.S. Food and Drug Administration (FDA), Humanitarian Device Exemption (HDE) database · Source date: